Much progress has been made during the past 20 years in the treatment of sickle cell
disease. Identification of most affected infants by neonatal screening provides opportunities …

Developed by a private-sector panel of health care experts and a consumer representative,
this clinical practice guideline sets forth a comprehensive program for identifying …

Sickle cell disease (SCD) is a group of complex genetic disorders with multisystem
manifestations. This statement provides pediatricians in primary care and subspecialty …

Sickle cell disease (SCD) is a group of complex genetic disorders of hemoglobin with
multisystem manifestations. The scope of this clinical report is such that in-depth …

This clinical practice guideline sets forth a comprehensive program for identifying,
diagnosing, and treating newborns and infants with sickle cell disease and recommends …

Sickle cell disease (SCD) is a group of complex genetic disorders with multisystem
manifestations. This statement provides pediatricians in primary care and subspecialty …

Purpose: To familiarize primary care providers (PCPs) with the pathophysiological
processes, diagnostic evaluation, and medical management of sickle hemoglobinopathies …

Treatment advances over the past 25 years have significantly decreased morbidity and
mortality in children with sickle cell disease. Aggressive management of fever, early …

The AHCPR guideline on sickle cell disease has several strengths and many weaknesses.
For the practicing physician it is strongest in recommending medical management of infants …

Sickle cell disease is the most common inherited blood disorder in the United States. This
disorder of hemoglobin structure leads to a chronic hemolytic anemia and complex chronic …